Skip to main content
. 2003 Apr;69(4):2080–2086. doi: 10.1128/AEM.69.4.2080-2086.2003

TABLE 1.

Origin, serotype, molecular type, and PLB1 RFLP pattern of C. neoformans strains used in this study

Strain Origin Serotype Molecular typea RFLP profile
AvaI HindIII
Cryptococcus neoformans var. grubii
    BL-1 Lung, Australia A VNI A1 H1
    CN042 CSF, New Zealand A VNI A1 H1
    H99 CSF, USA A VNI A1 H1
    LA190 = 76(a) Pigeon droppings, Spain A VNI A1 H1
    LA193 = 6(a) Pigeon droppings, Spain A VNI A1 H1
    LA194 = I-01 CSF, Colombia A VNI A1 H1
    LA195 = I-21 CSF, Colombia A VNI A1 H1
    LA199 = I-50 CSF, Colombia A VNI A1 H1
    WM 148 CSF, Australia A VNI A1 H1
    CN037 CSF, New Zealand A VNII A2 H1
    CN038 CSF, New Zealand A VNII A2 H1
    CN039 CSF, New Zealand A VNII A2 H1
    CN041 CSF, New Zealand A VNII A2 H1
    LA327 = MLP-1473 CSF, Brazil A VNII A2 H1
    WM 626 CSF, Australia A VNII A2 H1
AD hybrid
    WM 328 = 88-1358 No data AD VNIII A3 H2
    WM 329 = 90-7031 No data AD VNIII A3 H2
    LA 184 = 2(c) CSF, Spain AD VNIII A3 H2
    LA 185 = 3(c) CSF, Spain AD VNIII A3 H2
    LA 192 = 4(a) Pigeon droppings, Spain AD VNIII A3 H2
    LA 317 = 138027 Blood, Argentina AD VNIII A3 H2
    RKI-A208 Pigeon droppings, Germany AD VNIII A3 H2
    RKI-M1644/90 Clinical, Germany AD VNIII A3 H2
    RKI-M364/98 Clinical, Germany AD VNIII A3 H2
    WM 339 = RU-27809 No data AD VNIII A3 H2
    TBS 28 Clinical, India AD VNIII A3 H2
    TBS 54 Clinical, India AD VNIII A3 H2
    WM 628 CSF, Australia AD VNIII A3 H2
Cryptococcus neoformans var. neoformans
    B3501 = ATCC 52817 CSF, USA D VNIV A4 H3
    B-87455 Blood, Australia D VNIV A4 H3
    CN3501 = ATCC 52817 CSF, USA D VNIV A4 H3
    RKI-318 Clinical, Germany D VNIV A4 H3
    RKI-1089/89 Clinical, Germany D VNIV A4 H3
    RKI-M186/99 Clinical, Germany D VNIV A4 H3
    TP0416a Eucalyptus debris, Australia D VNIV A4 H3
    WM 629 Blood, Australia D VNIV A4 H3
Cryptococcus neoformans var. gattii
    LA174 = 48(a) Goat, Spain B VGI A5 H4
    LA175 = 50(a) Goat, Spain B VGI A5 H4
    LA176 = 52(a) Goat, Spain B VGI A5 H4
    LA177 = 54(a) Goat, Spain B VGI A5 H4
    LA178 = 56(a) Goat, Spain B VGI A5 H4
    LA179 = 58(a0 Goat, Spain B VGI A5 H4
    LA220 = I-628 CSF, Colombia B VGI A5 H4
    SAVIM No data, Papua New Guena B VGI A5 H4
    WM 276 = TSC/SC1 Eucalyptus debris, Australia B VGI A5 H4
    WM 179 CSF, Australia B VGI A5 H4
    WOWOPA No data, Papua New Guena B VGI A5 H4
    LA196 = I-34 CSF, Colombia B VGII A6 H4
    LA221 = I-638 CSF, Colombia B VGII A6 H4
    LA222 = I-642 CSF, Colombia B VGII A6 H4
    LA230 = I-357 CSF, Colombia B VGII A6 H4
    LA231 = I-414 CSF, Colombia B VGII A6 H4
    ATCC 32608 = NIH191 CSF, USA C VGII A6 H4
    ARN1 Eucalyptus debris, Australia B VGII A6 H4
    WM 178 Lung, Australia B VGII A6 H4
    ATCC 34880 CSF, USA C VGIII A7 H4
    CN043A CSF, New Zealand C VGIII A7 H4
    CN0438 CSF, New Zealand C VGIII A7 H4
    LA205 = I-78 CSF, Colombia C VGIII A7 H4
    LA234 = I-559 Almond tree, Colombia C VGIII A7 H4
    LA235 = I-737 Almond tree, Colombia C VGIII A7 H4
    LA237 = I-871 Almond tree, Colombia C VGIII A7 H4
    LA382 = BV19 CSF, Venezuela C VGIII A7 H4
    UCLA380 No data, USA C VGIII A7 H4
    UCLA385 No data, USA C VGIII A7 H4
    WM 161 Eucalyptus debris, USA B VGIII A7 H4
    WM 728 Eucalyptus depris, USA B VGIII A7 H4
    B5242 Clinical, India B VGIV A8 H5
    V869 Urine, South Africa C VGIV A8 H5
    V709 Urine, South Africa C VGIV A8 H5
    M27055 Urine, South Africa C VGIV A8 H5
    MCS34 CSF, Thailand C VGIV A8 H5
    WM 779 Cheata, South Africa C VGIV A8 H5
a

Molecular type as determined by PCR-fingerprinting with the minisatellite specific primer M13 (21).